Omeprazole
- TRADE NAME: Antra; Audazol; Gastroloc; Inhibitron; Logastric; Losec; Mopral; Omed; Ozoken; Parizac; Prilosec (AstraZeneca); Ulsen
- INDICATIONS: Duodenal ulcer, gastric ulcer, gastroesophageal reflux disease (GERD), erosive esophagitis
- CLASS: Proton pump inhibitor
- HALF-LIFE: 0.5–1 hour
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amoxicillin, Atazanavir, Bendamustine, Benzodiazepines, Cilostazol, Clarithromycin, Clobazam, Clopidogrel, Clozapine, Coumarins, Cyclosporine, Diazepam, Digoxin, Disulfiram, Erlotinib, Escitalopram, Eucalyptus, Itraconazole, Ketoconazole, Lapatinib, Methotrexate, Nelfinavir, Phenytoin, Posaconazole, Prednisone, Raltegravir, Rilpivirine, Saquinavir, St John's Wort, Tacrolimus, Tipranavir, Ulipristal, Voriconazole, Warfarin
PREGNANCY CATEGORY: C
Safety and effectiveness in pediatric patients <1 year of age have not been established.
Please login to see the rest of this drug profile
SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
HEMATOLOGIC
OTIC
OCULAR
OTHER
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric